Mitigating Antimalarial Resistance Consortium in South-East Africa: Kick-Off meeting in Zanzibar
Zanzibar, Tansania
May 9-11, 2023 - MARC SE-Africa team members convened in Zanzibar for a first in-person meeting to discuss project activities over the coming four years.
Led by University of Cape Town (UCT), MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) is a project with the goal to better define the extent of antimalarial resistance regionally and even more importantly, expedite the sharing of such evidence with National Malaria Programmes and their implementation partners. The consortium will provide technical support to the eighteen countries of Southern and East Africa, the area historically first affected by drug resistant malaria.
The ambitious undertaking requires strong collaboration and expertise from different fields. The breadth of research expertise in the broadly inter-disciplinary consortium includes malaria epidemiology, social sciences, clinical pharmacology, infectious diseases medicine, molecular biology, biomedical statistics and mathematical modelling, as well as public health and health policy. Delegates from all ten consortium members (in alphabetical order: Infectious Diseases Research Collaboration, Karolinska Institutet, LINQ management GmbH, Liverpool School of Tropical Medicine and their Malawi-Liverpool-Wellcome Programme, Stichting Amsterdam Institute for Global Health and Development, Stiftelsen Magic Evidence Ecosystem, University of Cape Town, University of Oxford, University of Melbourne, and the University of Rwanda) attended the three-day kick-off meeting in order to jointly discuss their work packages and plan the upcoming project activities in more detail. This in-person meeting offered the opportunity to team up and to foster a fruitful spirit of collaboration.
MARC SE-Africa is supported by the Global Health EDCTP3 Joint Undertaking and its members established under the European Union's research and innovation programme, Horizon Europe.
The project is is coordinated by the University of Cape Town (UCT) and managed by LINQ management GmbH.
More about the GH EDCTP3 JU
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) builds on the first and second European and Developing Countries Clinical Trials Partnership (EDCTP) programmes. This new joint undertaking is a partnership between the EU and the EDCTP Association, whose members are several European and African countries. The partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
